Dr Yousseff Zeidan, MD from Lynn Cancer Institute comments on the role of the multidisciplinary team (MDT) in breast cancer care: Interaction and alignment of surgeons, nurses, pathologists, radiologists, social workers, and other specialists to optimize treatment in challenging cases.

Dr Starr Mautner, MD from Miami Cancer Institute comments on the role of the multidisciplinary team in breast cancer management: Integration of breast surgical oncology, medical oncology, and radiation oncology, along with genetic counselors and breast reconstructive surgeons to develop a more personalized approach.

Dr Naomi Dempsey, MD from Miami Cancer Institute comments on the use of circulating tumor DNA (ctDNA) methodologies in breast cancer: Liquid biopsy to detect actionable molecular alterations in the metastatic setting, and a more investigational use in primary breast cancer to monitor for minimal residual disease.

Dr Maria Rueda-Lara, MD from University of Miami comments on the emotional impact of a cancer diagnosis: Navigating cancer patients through anxiety, depression, body image, sexuality, and other issues in a multidisciplinary setting.

Ms. Debbie Denardi, a breast cancer survivor and patient advocate from FORCE, comments on the role of advocacy organizations in breast cancer: Assisting the cancer patient with peer support, education, and financial assistance through a cancer diagnosis, survivorship programs, and mentoring for participation in research and policy making.